Skip to content
10-Q

Quarterly Report

CENTESSA PHARMACEUTICALS PLC CNTA

0001847903-25-000156

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 134.45M sh
Shares Diluted Q3 2025 · Sep 30, 2025 134.16M sh
Shares Diluted Q3 2025 · Sep 30, 2025 133.63M sh
Shares Diluted Q3 2025 · Sep 30, 2024 116.25M sh
Shares Diluted Q3 2025 · Sep 30, 2024 108.57M sh
Capex Q3 2025 · Sep 30, 2025 $360K
Capex Q3 2025 · Sep 30, 2024 $34K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$138.01M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$99.26M
Long Term Debt Q3 2025 · Sep 30, 2025 $109.82M
Long Term Debt Q3 2025 · Dec 31, 2024 $108.94M
Short Term Investments Q3 2025 · Sep 30, 2025 $195.4M
Short Term Investments Q3 2025 · Dec 31, 2024 $98.96M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $50.81M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $383.22M
Stockholders Equity Q3 2025 · Sep 30, 2025 $301.57M
Stockholders Equity Q3 2025 · Jun 30, 2025 $344.92M
Stockholders Equity Q3 2025 · Dec 31, 2024 $401.55M
Stockholders Equity Q3 2025 · Sep 30, 2024 $499.14M
Stockholders Equity Q3 2025 · Jun 30, 2024 $286.97M
Stockholders Equity Q3 2025 · Dec 31, 2023 $236.24M
Current Liabilities Q3 2025 · Sep 30, 2025 $29.12M
Current Liabilities Q3 2025 · Dec 31, 2024 $58M
Total Liabilities Q3 2025 · Sep 30, 2025 $146.73M
Total Liabilities Q3 2025 · Dec 31, 2024 $175.25M
Current Assets Q3 2025 · Sep 30, 2025 $307.68M
Current Assets Q3 2025 · Dec 31, 2024 $536.41M
Total Assets Q3 2025 · Sep 30, 2025 $448.3M
Total Assets Q3 2025 · Dec 31, 2024 $576.8M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.41
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.98
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.37
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.15
Eps Basic Q3 2025 · Sep 30, 2025 −$0.41
Eps Basic Q3 2025 · Sep 30, 2025 −$0.98
Eps Basic Q3 2025 · Sep 30, 2024 −$0.37
Eps Basic Q3 2025 · Sep 30, 2024 −$1.15
Sga Expense Q3 2025 · Sep 30, 2025 $12.23M
Sga Expense Q3 2025 · Sep 30, 2025 $36.47M
Sga Expense Q3 2025 · Sep 30, 2024 $12.5M
Sga Expense Q3 2025 · Sep 30, 2024 $37.11M
Net Income Q3 2025 · Sep 30, 2025 −$54.89M
Net Income Q3 2025 · Sep 30, 2025 −$131.37M
Net Income Q3 2025 · Sep 30, 2024 −$42.57M
Net Income Q3 2025 · Sep 30, 2024 −$124.43M
Operating Income Q3 2025 · Sep 30, 2025 −$53.79M
Operating Income Q3 2025 · Sep 30, 2025 −$139.22M
Operating Income Q3 2025 · Sep 30, 2024 −$46.41M
Operating Income Q3 2025 · Sep 30, 2024 −$126.48M
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2025 $15M
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $0